fMRI of Stress in Smoking Behavior
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To examine the influence of current daily tobacco smoking on brain activation during stress, tobacco cue, and neutral relaxing conditions
| Condition |
|---|
|
Smoking |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | fMRI of Stress in Smoking Behavior |
| Estimated Enrollment: | 60 |
| Study Start Date: | February 2008 |
| Estimated Study Completion Date: | February 2014 |
| Estimated Primary Completion Date: | February 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Smokers
Nicotine dependent individuals otherwise medically healthy
|
|
Healthy
Medically healthy individuals who do not smoke
|
Detailed Description:
Subjects will participate in an fMRI session to examine changes in frontal and limbic brain regions with tobacco cues, stress and neutral/relaxing imagery. During each fMRI session subjects will participate in six imagery trials: 2 different neutral/relaxing, 2 different stress and 2 different tobacco cue scripts.
Eligibility| Ages Eligible for Study: | 18 Years to 50 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
30 tobacco dependent and 30 matched healthy controls who have never smoked will be recruited for this study
Inclusion Criteria:
- age 18-50 years inclusive;
- able to read and write English;
- for women, being in follicular phase of menstrual cycle;
5) Tobacco dependent sample: smokes 10 or more cigarettes daily for the past year; Non-smokers, no tobacco consumption for more than one year and never having used tobacco daily.
Exclusion Criteria:
- any major neurological illness or injury and any current or prior clinically significant mental health (including PTSD) or substance use disorder (with possible exception of nicotine dependence) as determined by SCID interview;
- use of any psychoactive medication within past four weeks;
- any significant unstable medical condition such as asthma or heart disease for which increased cardiovascular reactivity during stress challenge might constitute a significant risk;
- IQ<70 based on past intelligence testing;
- any metal in body that would pose a risk with MRI; and
- claustrophobia that would interfere with MRI;
- alcohol and drug use in the 72 hours prior to scanning, with the exception of tobacco;
- pregnancy for women.
Contacts and Locations| Contact: Scott Bullock | 2037373390 | scott.bullock@yale.edu |
| United States, Connecticut | |
| Yale University School of Medicine | Recruiting |
| New Haven, Connecticut, United States, 06510 | |
| Contact: Rachel Hart rachel.hart@yale.edu | |
| Principal Investigator: Marc Potenza, MD, PhD | |
| Principal Investigator: | Marc Potenza, MD, PhD | Yale University |
More Information
No publications provided
| Responsible Party: | Yale University |
| ClinicalTrials.gov Identifier: | NCT01719471 History of Changes |
| Other Study ID Numbers: | 0805003898, RL1AA017539 |
| Study First Received: | October 29, 2012 |
| Last Updated: | October 29, 2012 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Smoking Habits |
ClinicalTrials.gov processed this record on May 19, 2013